Immunotherapy

Preclinical efficacy of dendritic cell immunotherapy for CNS tumors

A. B. Heimberger M.D., L. E. Crotty B.S., G. E. Archer Ph.D., R. E. McLendon M.D., D. D. Bigner M.D., Ph.D., and J. H. Sampson M.D., Ph.D.

Uptake and differential degradation of p53 mutants by dendritic cells from necrotic Saos-p53 positive cells.

S.E.B. McArdle, R. Germack, Selman Ali, R. C Rees.

Tumour associated antigen ctls induced by direct intra-tumour injection of disc-hsv specifically traffic to parental tumour microcirculation in murine model

SA Ali

Association of clinical and immunological responses to an autologous, hapten-modified human cancer vaccine.

D. Berd, MD

Human immunoRNases as selective and non-immunogenic anticancer agents

G. D'Alessio, PhD, MD C. De Lorenzo, PhD , D. Palmer , R. Piccoli

Immunisation with a nonapeptide expressed in human tumors is able to reduce tumor growth in a rat experimental model.

P. Sinibaldi Vallebona, G. Rasi, P. Bernard, P. Pierimarchi, F.G uadagni, E. Garaci

Exploitation of photodynamic therapy-generated immune response in cancer immunotherapy

M Korbelik, Ph.D.

Quantitative and qualitative deficits of peripheral gd T cells in patients with active nasopharyngeal carcinoma

BJ Zheng MD, PhD, SP Ng PhD, D Chua MD, JST Sham MD, D Kwong MD, CK Lam MD, MH Ng PhD

A monoclonal antibody for esophageal squamous cell carcinoma and immunotargeting therapy.

T. Tanaka MD, U. Toh MD, T. Fujii MD, S. Sueyoshi MD, H. Fujita MD, K. Shirouzu MD, H. Yamana MD.

Immunopathological study of secretory Iga expression in helicobacter pylori-infected gastric mucosa

KD Dimopoulou, E. Kairi-Vassilatou, M. Frangou, PhD, M.Eglezou, K. Kontoyanni MD, A. Kondi-Pafiti

Effects of TGFbeta on B cells of vaccinated NOD mice are dependent on costimulation via CD40: role for inhibitory Smads?

TC Martins, PhD, AP Águas, MD, PhD

The protective role of IgE in ovarian carcinoma.

SN Karagiannis, PhD Q Wang, PhD, N East, BSc, F Burke, PhD, FR Balkwill, PhD and HJ Gould, PhD

Anti-idiotypic antibodies induced by genetic immunization are directed exclusively against combined V_(L)/V_(H) determinants: implications on the mechanism of protection

F. Benevenuti , M. Cesco-Gaspere , O.R. Burrone

The influence of low dose recombinant interleukin-2 (rIL-2) therapy on immunological system of patients previously treated with purine analogues.

MM Malek,MD, A.Dmoszynska MD, PhD, A.Goracy MSc, D.Jawniak MD, W.Legiec MD.

Bcl-2 antisense oligonucleotides in the treatment neoplastic diseases in children

A. Chybicka, R. Chaber, J. Toporski

Immature and mature dendritic cells in mammary Paget's disease.

T Brunhuber, MD, C Ensinger, MD, G Mikuz, MD, N Romani, PhD, S Saeland, PhD, S Lebecque, PhD, P Obrist, MD

Immune system alterations in lung cancer patients

G Mazzoccoli , M Grilli , S Carughi , F Puzzolante , A De Cata , M La Viola , A Giuliani , R Tarquini , F Perfetto

The predictive value of tumour-infiltrating lymphocytes for response to immunotherapy.

A. Håkansson M.D., Ph.D. , B. Gustafsson M.D., Ph.D. and L. Håkansson M.D., Ph.D.

Effects of oral administration of Echinacea purpurea (American herb) and Pfaffia paniculata (Brazilian ginseng) in combination with iso-maltooligomers derived from corn starch on incidence of spontaneous leukemia in AKR/J mice

T Watanabe PhD , T Asahi , M Watanabe , Y Watanabe , Y Yanagimoto MD